Location: Home
  • search
  • go
  • Relate News
  • 3/9/2023Sino Biopharma's invoX Pharma Completes Acquisition of F-star Therapeu...
  • 3/9/2023NHSA Releases Its 2022 Healthcare Security Sector Development Statisti...
  • 3/9/2023PhIIC: Chinese Retail Pharmacy Sales Fell Sharply in 2022 Despite Rebo...
  • 3/8/2023J&J and Biocytogen Enter Non-exclusive License Deal for Antibody-based...
  • 3/8/2023Projected Rapid Growth in Diabetes Disease Burden and Economic Burden ...
  • 3/7/2023China to Restructure Government to Facilitate SciTech Self-Reliance wi...
  • 3/6/2023US Adds 37 Chinese Firms to Trade Blacklist, Including Units of BGI
  • 3/6/2023China Issues the 2023 Task Highlights of the National Patriotic Health...
  • 3/6/2023CNNIC Publishes 51st Statistical Report on Chinese Internet Developmen...
  • 3/6/20232023 Government Work Report on Healthcare: Promote Vaccine Development...
  • 3/6/2023The Future Pharmaceutical Strategy Seeks European Leadership in the US...
  • 3/4/2023China's 8th Round of National Level VBP Underway amid Growing Financia...
  • 3/4/2023Drug R&D and Product Registration News Digest March 2023 (1)
  • 3/3/2023JPO Issues Bidding Documents for the 8th Round of Volume-Based Procure...
  • 3/3/2023China: Commercial Health Insurance Trends (Simon Kucher)
  • 3/2/2023China's NRDL Adds 121 New Products, Prices Slashed by An Average Of 60...
  • 3/1/2023NHSA Issues the Notice on Centralized Drug Procurement and Price Contr...
  • 2/28/2023Northeast Pharma Fined $19M for Jacking Up Drug Ingredient Prices
  • 2/28/2023Four Central Government Agencies Issue the Measures for Ethical Review...
  • 2/28/2023Financial-related Company News Digest (February 2023)
  • 2/28/2023Why China's Rare Disease Burden Could Be An Opportunity for Innovation...
  • 2/28/2023Lesson from China's National Negotiation of Drug Prices in 2022 (NLR)
  • 2/27/2023Eucure and Chipscreen NewWay Enter into Greater China License Agreeme...
  • 2/27/2023HKUST, PhIRDA Launch Innovation and Research Platforms
  • 2/24/2023China Introduces New Policy to Deepen Reform and Promote Development o...
  • 2/24/2023SMEI: Chinese Pharma Revenues Down 1.6% Last Year But Expected to Rebo...
  • 2/24/2023IQVIA: Chinese Hospital Drug Market Shrank 2.1% in 2022
  • 2/24/2023Recent Official and Executive Moves
  • 2/24/2023Drug R&D and Product Registration News Digest February 2023 (4)
  • 2/24/2023The Out-Licensing Boom Continues, Orphan Drugs May Be on the Rise (Pha...
  • Page:54/719 Total number of articles:21546: [First][<<] [52] [53] [54] [55] [56] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group